- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00799487
CONCERTA Lab School Study
February 28, 2020 updated by: Ortho-McNeil Janssen Scientific Affairs, LLC
Double-Blind, Randomized, Placebo-Controlled, Crossover Study Evaluating the Academic, Behavioral and Cognitive Effects of CONCERTA on Older Children With ADHD (The ABC Study)
The purpose of this trial is to determine if the study medication, CONCERTA (methylphenidate HCl), is safe and effective in improving academic performance and behavior in children with Attention Deficit Hyperactivity Disorder (ADHD) when compared to placebo.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The hypothesis is that CONCERTA (methylphenidate HCl) is safe and effective in improving academic performance and behavior in children with ADHD when compared to placebo as demonstrated using specified study measures.
This is a double-blind (neither participant nor investigator knows the name of the assigned study drug), randomized (study drug assigned by chance), placebo-controlled, crossover study evaluating the academic, behavioral and cognitive effects of CONCERTA (methylphenidate HCl) on older children with ADHD This means that all eligible children will receive treatment with methylphenidate HCl throughout the study (the titration and assessment periods) and inactive pill (placebo) on 1 of the 2 laboratory classroom days.
On the other laboratory classroom day they will receive their regular dose of CONCERTA (methylphenidate HCl).
The primary efficacy variable in this study is the Permanent Product Math Test (PERMP) attempted score.
Secondary Measures include: SKAMP (Swanson, Kotkin, Agler, M-Flynn, and Pelham), tests of inattention, reading fluency and comprehension, and memory.
Assessments will be completed during each of the laboratory assessment days (12.5 hours).
Participants will be assessed for adverse events throughout the study.
Patients will initiate treatment with oral CONCERTA (methylphenidate HCl) 18 mg at baseline and continue morning dosing with increases every 3 to 7 days until an optimal dose is achieved, up to the maximum of 54 mg/day.
Eligible patients will remain in the study for a maximum of 8 weeks.
Study Type
Interventional
Enrollment (Actual)
89
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Arkansas
-
Little Rock, Arkansas, United States
-
-
Nevada
-
Las Vegas, Nevada, United States
-
-
North Carolina
-
Durham, North Carolina, United States
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
7 years to 10 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- ADHD diagnosis of all subtypes (except Not Otherwise Specified)
- Patients with total or subscale Attention Deficit Hyperactivity Disorder Rating Scale (ADHD RS-IV) scores > =90th percentile relative to the general population of children by age and gender
- Patients currently receiving ADHD medication must be inadequately managed on their current stimulant dose and meet this criteria at the screening visit
- Ability to read and understand English
- Ability to attend school regularly
Exclusion Criteria:
- Estimated Full Scale IQ score of 80 or below, Severe Learning Disability
- History of or current, primary diagnosis of: severe anxiety disorder, conduct disorder, psychotic disorders, Pervasive Developmental Disorder, Eating Disorder, Obsessive-Compulsive Disorder, Sleep Disorder, Major Depressive Disorder, Bipolar Disorder, Substance Use Disorder, Chronic Tic Disorder, personal or family history of Tourette's Syndrome
- Weight < 3rd percentile for age
- History of hospitalization for treatment of a mood, anxiety, or psychotic disorder
- History of failed response to methylphenidate
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
CONCERTA (methylphenidate HCl) or placebo Optimal Subject Dose (18mg-54mg) once daily during Lab School Day #1 with placebo on Day #2
|
Optimal Subject Dose (18mg-54mg) once daily during Lab School Day #1 with placebo on Day #2
Optimal Subject Dose (18mg-54mg) once daily during Lab School Day #2 with placebo on Day #1
|
Experimental: 2
CONCERTA (methylphenidate HCl) or placebo Optimal Subject Dose (18mg-54mg) once daily during Lab School Day #2 with placebo on Day #1
|
Optimal Subject Dose (18mg-54mg) once daily during Lab School Day #1 with placebo on Day #2
Optimal Subject Dose (18mg-54mg) once daily during Lab School Day #2 with placebo on Day #1
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hour 4 Permanent Product Math Test Attempted Score (PERMP-Attempted)
Time Frame: Hour 4 of the Double-Blind Assessment Period Lab School Day
|
PERMP (range: 0, 400) is a measure of academic productivity.
These seatwork math tasks provide an objective measure of attention and accuracy in calculations.
The level of difficulty is established on a screening math pretest.
The subsequent laboratory school day assessments employed a series of 10-minute math tests (5 pages of 80 math problem each for a total of 400 problems available).
Children were graded on the number of attempted problems.
A higher number of problems attempted was indicative of greater attention to detail (higher score is preferable.)
|
Hour 4 of the Double-Blind Assessment Period Lab School Day
|
Hour 4 Permanent Product Math Test Correct Score (PERMP-Correct)
Time Frame: Hour 4 of the Lab School Day During the Double-Blind Assessment Period
|
PERMP (range: 0, 400) is a measure of academic productivity.
These seatwork math tasks provide an objective measure of attention and accuracy in calculations.
The level of difficulty is established on a screening math pretest.
The subsequent laboratory school day assessments employed a series of 10-minute math tests (5 pages of 80 math problem each for a total of 400 problems available).
Children were graded on the number of correct problems.
A higher number of problems correct, of those attempted, was indicative of greater accuracy.
|
Hour 4 of the Lab School Day During the Double-Blind Assessment Period
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hour 5.5 Wide Range Assessment of Memory and Learning (WRAML-2) Finger Windows Backwards
Time Frame: Hour 5.5 of the Lab School Day During the Double-Blind Assessment Period
|
WRAML-2 (range: 0, 28) is designed to evaluate a child's ability to learn and to memorize information, consists of 9 subtests from which 4 summary indexes can be calculated: verbal memory index, visual memory index, learning index, and general memory index.
During this test the investigator pointed to a longer and longer series of windows on a card at the rate of 1 location per second, and then the child was asked to reproduce the sequence exactly in reverse order.
One point was given for each correctly recalled sequence, and the test was discontinued after 3 consecutive errors.
|
Hour 5.5 of the Lab School Day During the Double-Blind Assessment Period
|
Hour 5.5 Wide Range Assessment of Memory and Learning (WRAML-2) Finger Windows Forwards
Time Frame: Hour 5.5 of the Lab School Day During the Double-Blind Assessment Period
|
WRAML-2 (range: 0, 28) is designed to evaluate a child's ability to learn and to memorize information, consists of 9 subtests from which 4 summary indexes can be calculated: verbal memory index, visual memory index, learning index, and general memory index.
During this test the investigator pointed to a longer and longer series of windows on a card at the rate of 1 location per second, and then the child was asked to reproduce the sequence exactly.
One point was given for each correctly recalled sequence, and the test was discontinued after 3 consecutive errors.
|
Hour 5.5 of the Lab School Day During the Double-Blind Assessment Period
|
Hour 5.5 Wechsler Intelligence Scale for Children - 3rd ed. (WISC-III-PI) Digit Span Backwards
Time Frame: Hour 5.5 of the Lab School Day During the Double-Blind Assessment Period
|
Each child individually was given a sequence of numbers with the sequence becoming progressively longer.
The child was then asked to repeat the digits in the same sequence, either forwards or backwards.
Each sequence length was attempted twice.
The test was complete after failure on both trials of any sequence length.
One point was awarded if the participant passed only 1 trial of a sequence length.
Zero points were given if the participant failed both trials.
The maximum raw scores were 16 forwards and 14 backwards.
A higher score was indicative of better recall and attention (range: 0, 14).
|
Hour 5.5 of the Lab School Day During the Double-Blind Assessment Period
|
Hour 5.5 Wechsler Intelligence Scale for Children - 3rd ed. (WISC-III-PI) Digit Span Forwards
Time Frame: Hour 5.5 of the Lab School Day During the Double-Blind Assessment Period
|
Each child individually was given a sequence of numbers with the sequence becoming progressively longer.
The child was then asked to repeat the digits in the same sequence, either forwards or backwards.
Each sequence length was attempted twice.
The test was complete after failure on both trials of any sequence length.
One point was awarded if the participant passed only 1 trial of a sequence length.
Zero points were given if the participant failed both trials.
The maximum raw scores were 16 forwards and 14 backwards.
A higher score was indicative of better recall and attention (range: 0, 16).
|
Hour 5.5 of the Lab School Day During the Double-Blind Assessment Period
|
Hour 4 Swanson, Kotkin, Alger, M-Flynn and Pelham Scale for Deportment (SKAMP-Deportment)
Time Frame: Hour 4 of the Lab School Day During the Double-Blind Assessment Period
|
The SKAMP scale measures the manifestations of ADHD using an independent observer (teacher) rating of children impairment in classroom behavior.
The SKAMP-Deportment (SKAMP-D) (range: 0,36) is a sum of ratings on 6 deportment items (interacting with other children, interacting with adults, remaining quiet, staying seated, complying with the teacher's directions, and following the classroom rules).
Each item was rated on a 7-point impairment scale (0=normal, 6=maximum impairment), with higher scores indicating more severe symptoms.
|
Hour 4 of the Lab School Day During the Double-Blind Assessment Period
|
Hour 4 Swanson, Kotkin, Alger, M-Flynn and Pelham Scale for Attention (SKAMP-Attention)
Time Frame: Hour 4 of the Lab School Day During the Double-Blind Assessment Period
|
The SKAMP scale measures the manifestations of ADHD using an independent observer (teacher) rating of children impairment in classroom behavior.
The SKAMP-Attention (SKAMP-A) (range: 0, 42) is a sum of the ratings on 7 attention items (getting started, sticking with tasks, attending to an activity, making activity transitions, completing assigned tasks, performing work accurately, and being neat and careful while writing or drawing).
Each item was rated on a 7-point impairment scale (0=normal, 6=maximum impairment), with higher scores indicating more severe symptoms.
|
Hour 4 of the Lab School Day During the Double-Blind Assessment Period
|
Hour 4 Swanson, Kotkin, Alger, M-Flynn and Pelham Scale for Composite (SKAMP-Composite)
Time Frame: Hour 4 of the Lab School Day During the Double-Blind Assessment Period
|
The SKAMP scale measures the manifestations of ADHD using an independent observer (teacher) rating of child impairment in classroom behavior.
A composite score (range: 0, 78) for the SKAMP variable (13 items total) was obtained by summing the SKAMP-D and SKAMP-A subscale scores.
A lower score was preferable, as a higher score represented greater behavioral impairment.
|
Hour 4 of the Lab School Day During the Double-Blind Assessment Period
|
Hour 5.5 Test of Variables of Attention (TOVA) ADHD Score
Time Frame: Hour 5.5 of the Lab School Day During the Double-Blind Assessment Period
|
The TOVA is a computerized, visual continuous performance test which provides measures of attention.
The stimulus, presented for 100 milliseconds (ms) at the rate of 30 per minute, is a computer-presented square containing a square hole near the top (target) or bottom (non-target) edge.
The first half of the TOVA requires that the child sustain attention while the second half requires inhibition of response to a non-target (observed range: -15.2, 5.2).
An ADHD score of less than -1.80 is suggestive of ADHD.
|
Hour 5.5 of the Lab School Day During the Double-Blind Assessment Period
|
Hour 5.5 Test of Variables of Attention (TOVA) Reaction Time (Msec)
Time Frame: Hour 5.5 of the Lab School Day During the Double-Blind Assessment Period
|
The TOVA is a computerized, visual continuous performance test which provides measures of attention.
The stimulus, presented for 100 milliseconds (ms) at the rate of 30 per minute, is a computer-presented square containing a square hole near the top (target) or bottom (non-target) edge.
The first half of the TOVA requires that the child sustain attention while the second half requires inhibition of response to a non-target.
Mean response latency in msecs (observed range: -75.4,
129.5).
Higher score indicates faster reaction time.
|
Hour 5.5 of the Lab School Day During the Double-Blind Assessment Period
|
Hour 5.5 Test of Variables of Attention(TOVA) Reaction Time Variability (Standard Deviation in Milliseconds (Msecs))
Time Frame: Hour 5.5 of the Lab School Day During the Double-Blind Assessment Period
|
The TOVA is a computerized, visual continuous performance test which provides measures of attention.
The stimulus, presented for 100 milliseconds (ms) at the rate of 30 per minute, is a computer-presented square containing a square hole near the top (target) or bottom (non-target) edge.
The first half of the TOVA requires that the child sustain attention while the second half requires inhibition of response to a non-target.
SD of response times (msecs) (observed range: -177.6,
132.9).
Higher score indicates less variability.
|
Hour 5.5 of the Lab School Day During the Double-Blind Assessment Period
|
Hour 5.5 Test of Variables of Attention (TOVA) Commissions
Time Frame: Hour 5.5 of the Lab School Day During the Double-Blind Assessment Period
|
The TOVA is a computerized, visual continuous performance test which provides measures of attention.
The stimulus, presented for 100 milliseconds (ms) at the rate of 30 per minute, is a computer-presented square containing a square hole near the top (target) or bottom (non-target) edge.
The first half of the TOVA requires that the child sustain attention while the second half requires inhibition of response to a non-target.
Responses to non-targets.
Higher score is preferable (observed range: -82.4,
128.9).
|
Hour 5.5 of the Lab School Day During the Double-Blind Assessment Period
|
Hour 8.75 Gray Silent Reading Test (GSRT)
Time Frame: Hour 8.75 of the Lab School Day During the Double-Blind Assessment Period
|
Gray Silent Reading Test (GSRT) is a reliable, validated measure of reading comprehension administered in the group setting during the first half hour of the homework session (observed range: 0, 141).
A higher score is preferable as it means more questions were answered correctly.
|
Hour 8.75 of the Lab School Day During the Double-Blind Assessment Period
|
Hour 7.5 Test of Handwriting Skills (Revised) (THS-R)
Time Frame: Hour 7.5 of the Lab School Day During the Double-Blind Assessment Period
|
The THS-R is a standardized, untimed assessment designed to evaluate neurosensory integration manifested in manuscript and cursive writing.
The test includes the 10 subtests: writing from memory the upper- and lower-case letters of the alphabet in order, writing from dictation the upper and lower-case letters of the alphabet out of order, single digit-numbers out of order, selected words, and copying selected letters, words, and sentences.
Each subtest was scored from zero (poorly formed letters) to 3 (perfectly formed letters).
A higher score was preferable (observed range: 0, 118).
|
Hour 7.5 of the Lab School Day During the Double-Blind Assessment Period
|
Hour 3.5 Dynamic Indicators of Basic Early Literacy Skills (DIBELS)
Time Frame: Hour 3.5 of the Lab School Day During the Double-Blind Assessment Period
|
The DIBELS (observed range: 0, 212), used to assess reading fluency, consists of standardized, individually administered measures of early literacy development.
These short (1 minute) fluency measures were developed based upon essential early literacy domains to assess development of phonological awareness, alphabetic understanding, and automaticity and fluency.
Only the paragraph fluency component of an age/grade-appropriate DIBELS was used.
Children read 3 stories and completed the forms.
A higher score was preferable and indicated a greater number of words read correctly in the time allowed
|
Hour 3.5 of the Lab School Day During the Double-Blind Assessment Period
|
Hour 5.5 Test of Variables of Attention (TOVA) Omissions
Time Frame: Hour 5.5 of the Lab School Day During the Double-Blind Assessment Period
|
The TOVA is a computerized, visual continuous performance test which provides measures of attention.
The stimulus, presented for 100 milliseconds (ms) at the rate of 30 per minute, is a computer-presented square containing a square hole near the top (target) or bottom (non-target) edge.
The first half of the TOVA requires that the child sustain attention while the second half requires inhibition of response to a non-target.
Number of targets missed.
Higher score is preferable (observed range: -419.4,
108.9).
|
Hour 5.5 of the Lab School Day During the Double-Blind Assessment Period
|
Hour 3.0 Grammar Task
Time Frame: Hour 3.0 of the Lab School Day During the Double-Blind Assessment Period
|
This task, presented once during a laboratory school day, was designed to index "attention to detail" by determining how many grammatical mistakes each child could identify and circle in a brief paragraph.
The errors were not difficult to identify and were designed to show attention to task, not comprehension.
A higher number of errors identified, of those possible, was indicative of better attention - identification of grammatical errors (range: 0, 1 represents correct responses divided by the number of possible responses).
|
Hour 3.0 of the Lab School Day During the Double-Blind Assessment Period
|
Hour 8.75 Packet Activity - Short Story With Questions for Comprehension
Time Frame: Hour 8.75 of the Lab School Day During the Double-Blind Assessment Period
|
Packet Activities: Assessment of ability to organize, listen to instructions, initiate task, complete task, and distractibility, by completing a word search, reading a short story for comprehension on a multiple choice test, reading a longer story for comprehension on a true/false test, decoding a mystery sentence, and completing various vocabulary assessments (word choice, homophones; base/root words, alphabetic order)(range: 0, 1 represents correct responses divided by the number of possible responses).
|
Hour 8.75 of the Lab School Day During the Double-Blind Assessment Period
|
Hour 8.75 Packet Activity - Identiy Root Word
Time Frame: Hour 8.75 of the Lab School Day During the Double-Blind Assessment Period
|
Packet Activities: Assessment of ability to organize, listen to instructions, initiate task, complete task, and distractibility, by completing a word search, reading a short story for comprehension on a multiple choice test, reading a longer story for comprehension on a true/false test, decoding a mystery sentence, and completing various vocabulary assessments (word choice, homophones; base/root words, alphabetic order) (range: 0, 1 represents correct responses divided by the number of possible responses).
|
Hour 8.75 of the Lab School Day During the Double-Blind Assessment Period
|
Hour 8.75 Packet Activity - Alphabetize List of Words
Time Frame: Hour 8.75 of the Lab School Day During the Double-Blind Assessment Period
|
Packet Activities: Assessment of ability to organize, listen to instructions, initiate task, complete task, and distractibility, by completing a word search, reading a short story for comprehension on a multiple choice test, reading a longer story for comprehension on a true/false test, decoding a mystery sentence, and completing various vocabulary assessments (word choice, homophones; base/root words, alphabetic order) (range: 0, 1 represents correct responses divided by the number of possible responses).
|
Hour 8.75 of the Lab School Day During the Double-Blind Assessment Period
|
Hour 8.75 Packet Activity - Identify Multiple Meanings for Words
Time Frame: Hour 8.75 of the Lab School Day During the Double-Blind Assessment Period
|
Packet Activities: Assessment of ability to organize, listen to instructions, initiate task, complete task, and distractibility, by completing a word search, reading a short story for comprehension on a multiple choice test, reading a longer story for comprehension on a true/false test, decoding a mystery sentence, and completing various vocabulary assessments (word choice, homophones; base/root words, alphabetic order) (range: 0, 1 represents correct responses divided by the number of possible responses).
|
Hour 8.75 of the Lab School Day During the Double-Blind Assessment Period
|
Hour 8.75 Packet Activity - Complete Sentences Using Words Provided
Time Frame: Hour 8.75 of the Lab School Day During the Double-Blind Assessment Period
|
Packet Activities: Assessment of ability to organize, listen to instructions, initiate task, complete task, and distractibility, by completing a word search, reading a short story for comprehension on a multiple choice test, reading a longer story for comprehension on a true/false test, decoding a mystery sentence, and completing various vocabulary assessments (word choice, homophones; base/root words, alphabetic order) (range: 0, 1 represents correct responses divided by the number of possible responses).
|
Hour 8.75 of the Lab School Day During the Double-Blind Assessment Period
|
Hour 8.75 Packet Activity - Word Search
Time Frame: Hour 8.75 of the Lab School Day During the Double-Blind Assessment Period
|
Packet Activities: Assessment of ability to organize, listen to instructions, initiate task, complete task, and distractibility, by completing a word search, reading a short story for comprehension on a multiple choice test, reading a longer story for comprehension on a true/false test, decoding a mystery sentence, and completing various vocabulary assessments (word choice, homophones; base/root words, alphabetic order) (range: 0, 1 represents correct responses divided by the number of possible responses).
|
Hour 8.75 of the Lab School Day During the Double-Blind Assessment Period
|
Hour 8.75 Packet Activity - Decode the Mystery Sentence
Time Frame: Hour 8.75 of the Lab School Day During the Double-Blind Assessment Period
|
Packet Activities: Assessment of ability to organize, listen to instructions, initiate task, complete task, and distractibility, by completing a word search, reading a short story for comprehension on a multiple choice test, reading a longer story for comprehension on a true/false test, decoding a mystery sentence, and completing various vocabulary assessments (word choice, homophones; base/root words, alphabetic order) (range: 0, 1 represents correct responses divided by the number of possible responses).
|
Hour 8.75 of the Lab School Day During the Double-Blind Assessment Period
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 2, 2009
Primary Completion (Actual)
June 26, 2009
Study Completion (Actual)
June 26, 2009
Study Registration Dates
First Submitted
November 26, 2008
First Submitted That Met QC Criteria
November 26, 2008
First Posted (Estimate)
December 1, 2008
Study Record Updates
Last Update Posted (Actual)
March 12, 2020
Last Update Submitted That Met QC Criteria
February 28, 2020
Last Verified
February 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Mental Disorders
- Nervous System Diseases
- Neurologic Manifestations
- Dyskinesias
- Attention Deficit and Disruptive Behavior Disorders
- Neurodevelopmental Disorders
- Attention Deficit Disorder with Hyperactivity
- Hyperkinesis
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Neurotransmitter Uptake Inhibitors
- Membrane Transport Modulators
- Dopamine Agents
- Dopamine Uptake Inhibitors
- Central Nervous System Stimulants
- Methylphenidate
Other Study ID Numbers
- CR015118
- NCT00799487
- 2015-001042-28 (EudraCT Number)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention Deficit Hyperactivity Disorder
-
Cingulate TherapeuticsRecruitingPhase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301ADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Ornit CohenUnknownAttention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | Attention Deficit Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersIsrael
-
Cingulate TherapeuticsPremier Research Group plcActive, not recruitingADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Children's National Research InstituteRecruitingADHD | Attention Deficit Hyperactivity Disorder | Attention-Deficit Hyperactivity Disorder | Attention Deficit Disorder | ADD | ADHD Predominantly Inattentive Type | ADHD - Combined Type | ADHD, Predominantly Hyperactive - Impulsive | Attention-Deficit Disorder in Adolescence | Attention-Deficit Hyperactivity...United States
-
Fondation LenvalCompletedAttention Deficit Disorder With Hyperactivity | Attention Deficit Disorder Without HyperactivityFrance
-
University Hospital Bispebjerg and FrederiksbergMental Health Services in the Capital Region, DenmarkRecruitingSleep Disturbance | Neurodevelopmental Disorders | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder | Attention-Deficit Hyperactivity Disorder, Unspecified Type | Attention-deficit Hyperactivity | Hyperkinetic Conduct DisorderDenmark
-
Corium, Inc.Worldwide Clinical Trials; Premier Research Group plc; Almac; Prometrika, LLCRecruitingAttention Deficit/Hyperactivity DisorderUnited States
-
Corium, Inc.Premier Research Group plc; Almac; Prometrika, LLCRecruitingAttention Deficit/Hyperactivity DisorderUnited States
-
Massachusetts General HospitalShire Human Genetic Therapies, Inc.Active, not recruitingAttention Deficit/Hyperactivity DisorderUnited States
-
Atatürk UniversityCompletedAttention-deficit/Hyperactivity DisorderTurkey
Clinical Trials on CONCERTA (methylphenidate HCl) or placebo
-
Ortho-McNeil Janssen Scientific Affairs, LLCCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Massachusetts General HospitalMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.Completed
-
University of PittsburghOrtho-McNeil Janssen Scientific Affairs, LLCWithdrawnAttention-Deficit/Hyperactivity Disorder (ADHD)United States
-
Massachusetts General HospitalOrtho-McNeil Janssen Scientific Affairs, LLCCompleted
-
Purdue Pharma LPTerminatedAttention-Deficit/Hyperactivity DisorderUnited States
-
Noven TherapeuticsNoven Pharmaceuticals, Inc.CompletedAttention Deficit Disorder With Hyperactivity
-
Noven TherapeuticsCompletedAttention Deficit Hyperactivity Disorder
-
Nicoleta StoiceaCompletedDelayed Emergence From AnesthesiaUnited States
-
Massachusetts General HospitalMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.CompletedBipolar Disorder | ADHDUnited States
-
Janssen Korea, Ltd., KoreaCompletedAttention Deficit Disorder With Hyperactivity